TJE 231257.0 Module Four: Recognition, Diagnosis, and Treatment of SUD (Innovations and Smart Approaches in Safe Prescribing)

Course Instructions

Date & Location
Tuesday, May 9, 2023, 12:00 AM - Saturday, May 9, 2026, 12:00 AM

Target Audience
Specialties - Anesthesiology, Cardiology, Dentistry, Dermatology, Emergency Medicine, Family Medicine/Primary Care, General Surgery, Hospitalists, Internal Medicine, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Oral and Maxillofacial Surgery, Orthopedics, Other, Otolaryngology-Head/Neck, Pain Management, Pathology, Pediatrics, Plastic Surgery, Podiatry, Practice Managers, Psychiatry, Radiology
Professions - Physician

Credits
AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Attendance (0.50 hours)

Overview
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will be shown strategies for recognizing substance use disorder (SUD) and opioid use disorder (OUD). Refamiliarize yourself with screening for fentanyl. Provide valuable pharmacological and nonpharmacological resources to connect patients to treatment for addiction. Discuss individualized treatment plans that are tailored to specific patient needs when treating OUD. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Objectives
After completing this activity, learners will be able to:

  1. Implement strategies for recognizing Substance Use Disorder (SUD) and Opioid Use Disorder (OUD).
  2. Screen for fentanyl in all urine drug screens to reduce fentanyl related mortality.
  3. Provide pharmacological and non-pharmacological resources to connect patients to treatment for addiction in order to better assist recovering patients and their families.
  4. Develop individualized treatment plans that are tailored to specific patient needs when treating OUD.

Accreditation

The Doctors Company is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical educational activities for physicians. The Doctors Company designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Doctors Company and Champions for Health. The Doctors Company is accredited by the ACCME to provide continuing medical education for physicians.


Additional Information

Disclaimer
The information and guidelines contained in this activity are generalized and may not apply to all practice situations. We recommend that legal advice be obtained from a qualified attorney for specific application to your practice. The information is intended for educational purposes and should be used as a reference guide only.

State Requirements for Continuing Education
Please see your state licensing organization for continuing education requirements for your profession and specialty.

Accessibility
The Doctors Company is committed to ensuring that its programs, services, goods, and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodation, please contact the program coordinator or our CPE Coordinator.



Keywords: